Trevi Therapeutics (TRVI) had the highest return in March 2022 by a small-cap US stock, returning 224%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Trevi Therapeutics (TRVI) | March 2022 | 224.01% |
Dogness International Corp Class A (DOGZ) | March 2022 | 103.04% |
Voyager Therapeutics (VYGR) | March 2022 | 91.94% |
Target Hospitality (TH) | March 2022 | 91.69% |
SES AI (SES) | March 2022 | 86.21% |
Pennant (PNTG) | March 2022 | 63.71% |
Dave (DAVE) | March 2022 | 63.62% |
IGM Biosciences (IGMS) | March 2022 | 60.44% |
Innovid (CTV) | March 2022 | 58.53% |
Borr Drilling (BORR) | March 2022 | 56.55% |
Redwire (RDW) | March 2022 | 51.43% |
Revance (RVNC) | March 2022 | 50% |
UroGen Pharma (URGN) | March 2022 | 46.14% |
Kosmos Energy (KOS) | March 2022 | 45.55% |
TMC the metals (TMC) | March 2022 | 45.51% |
CVR Energy (CVI) | March 2022 | 45.11% |
Intrepid Potash (IPI) | March 2022 | 44.11% |
Qudian (QD) | March 2022 | 43.9% |
Eos Energy Enterprises (EOSE) | March 2022 | 43.15% |
Olympic Steel (ZEUS) | March 2022 | 42.87% |
Ardelyx (ARDX) | March 2022 | 42.67% |
BigBearai (BBAI) | March 2022 | 42.56% |
MannKind (MNKD) | March 2022 | 39.39% |
Eastman Kodak (KODK) | March 2022 | 38.48% |
Immunocore (IMCR) | March 2022 | 37.16% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
